Press & Publications
Press
- Respirics announces launch of MD Turbo
- FDA clears MD Turbo® for use with pMDIs
- Accentia Biopharmaceuticals to Begin Shipping MD Turbo®; First Product to Provide Metered Dose Inhaler Users with Breath-Activated Delivery and Dose-Counting Capabilities
- TEAMM Pharmaceuticals and Respirics team up on novel COPD product
Publications
- “A Tool for All Seasons: Making MDIs Breath-Triggered,” from the Association of Asthma Educators newsletter
- In Vitro Evaluation of Drug Particle Size Delivered from MDIs with a Breath-Actuation Device - American Association for Respiratory Care Congress (AARC), December 2005
- In Vitro Evaluation of Drug Delivery from (Mass) MDIs with a Breath-Actuation Device - American College of Allergy, Asthma and Immunology Annual Meeting (ACAAI), November 2005
